Best of the Week
Most Popular
1. 2019 From A Fourth Turning Perspective - James_Quinn
2.Beware the Young Stocks Bear Market! - Zeal_LLC
3.Safe Havens are Surging. What this Means for Stocks 2019 - Troy_Bombardia
4.Most Popular Financial Markets Analysis of 2018 - Trump and BrExit Chaos Dominate - Nadeem_Walayat
5.January 2019 Financial Markets Analysis and Forecasts - Nadeem_Walayat
6.Silver Price Trend Analysis 2019 - Nadeem_Walayat
7.Why 90% of Traders Lose - Nadeem_Walayat
8.What to do With Your Money in a Stocks Bear Market - Stephen_McBride
9.Stock Market What to Expect in the First 3~5 Months of 2019 - Chris_Vermeulen
10.China, Global Economy has Tipped over: The Surging Dollar and the Rallying Yen - FXCOT
Last 7 days
The US Interest Rate Hawks Surrender - 22nd Jan 19
The Specialist Lending Renaissance - 22nd Jan 19
The 5 Rules of Real Estate Investment - 22nd Jan 19
Semiconductor Sector – Watch the Early Bird in 2019 - 21st Jan 19
From ASEAN Economic Development to Militarization - 21st Jan 19
Will China Surprise The Us Stock Market? - 21st Jan 19
Tips to Keep Your Finances Healthy in 2019 and Beyond - 21st Jan 19
Tips for Writing Assignment in Hurry - 21st Jan 19
UK House Prices, Immigration, and Population Growth Mega Trend Forecast - 21st Jan 19
REMAIN Parliament to Subvert BrExit with Peoples Vote FIXED 2nd EU Referendum - 21st Jan 19
Pay Attention To The Russell Stocks Index and Financial Sectors - 20th Jan 19
Hyperinflation - Zimbabwe's Monetary Death Spiral - 20th Jan 19
Stock Market Counter-trend Extends - 20th Jan 19
The News About Fake News Is Fake - 20th Jan 19
Stock Market Bull Trap? January 22 Top Likely - 19th Jan 19
After the Crash, the Stock Market Made a V-shaped Recovery. What’s Next - 19th Jan 19
David Morgan: Expect Stagflation and Silver Outperformance in 2019 - 19th Jan 19
Why Brampton Manor Academy State School 41 Oxbridge Offers is Nothing to Celebrate! - 19th Jan 19
REMAIN Parliament Prepares to Subvert BrExit with Peoples Vote FIXED 2nd EU Referendum - 19th Jan 19
Gold Surges on Stock Selloff - 18th Jan 19
Crude Oil Price Will Find Strong Resistance Between $52~55 - 18th Jan 19
Stock Market’s Medium Term is No Longer Bullish. It is Now Mixed - 18th Jan 19
SPX and Gold; Pivotal Points at Hand - 18th Jan 19
Fable Media Launches New GoWin Online Casino Affiliate Site in UK - 18th Jan 19
The End of Apple! - 18th Jan 19
Debt, Division, Dysfunction, and the March to National Bankruptcy - 18th Jan 19
Creating the Best Office Space - 18th Jan 19
S&P 500 at Resistance Level, Downward Correction Ahead? - 17th Jan 19
Mauldin: My 2019 Economic Outlook - 17th Jan 19
Macro Could Weaken After US Government Shutdown. What This Means for Stocks - 17th Jan 19
US Stock Market Indexes Reaches Fibonacci Target Zone – Where to Next? - 17th Jan 19
How 2018 Was For The UK Casino Industry - 17th Jan 19
Gold Price – US$700 Or US$7000? - 16th Jan 19
Commodities Are the Right Story for 2019 - 16th Jan 19
Bitcoin Price Wavers - 15th Jan 19
History Shows That “Disruptor Stocks” Will Make You the Most Money in a Bear Market - 15th Jan 19
What Will the Stock Market Do Around Earnings Season - 15th Jan 19
2018-2019 Pop Goes The Debt Bubble - 15th Jan 19
Are Global Stock Markets About To Rally 10 Percent? - 15th Jan 19
Here's something to make you money in 2019 - 15th Jan 19
Theresa May to Lose by Over 200 Votes as Remain MP's Plot Subverting Brexit - 15th Jan 19
Europe is Burning - 14th Jan 19
S&P 500 Bounces Off 2,600, Downward Reversal? - 14th Jan 19
Gold A Rally or a Bull Market? - 14th Jan 19
Gold Stocks, Dollar and Oil Cycle Moves to Profit from in 2019 - 14th Jan 19
How To Profit From The Death Of Las Vegas - 14th Jan 19
Real Reason for Land Rover Crisis is Poor Quality of Build - 14th Jan 19
Stock Market Looking Toppy! - 13th Jan 19
Liquidity, Money Supply, and Insolvency - 13th Jan 19
Top Ten Trends Lead to Gold Price - 13th Jan 19
Silver: A Long Term Perspective - 13th Jan 19
Trump's Impeachment? Watch the Stock Market - 12th Jan 19
Big Silver Move Foreshadowed as Industrial Panic Looms - 12th Jan 19
Gold GDXJ Upside Bests GDX - 12th Jan 19
Devastating Investment Losses Are Coming: What Is Your Advisor Doing About It? - 12th Jan 19
Things to do Before Choosing the Right Credit Card - 12th Jan 19
Japanese Yen Outlook In 2019 - 11th Jan 19
Yield curve suggests that US Recession is near: Trading Setups - 11th Jan 19

Market Oracle FREE Newsletter

Category: BioTech

The analysis published under this category are as follows.

Companies

Friday, November 23, 2018

DNA Breakthrough: Scientists Repair Genes in Human Embryos / Companies / BioTech

By: Andrew_Cioffi

The medical field is set to change tremendously owing to a recent breakthrough by medical researchers. A team of researchers recently managed to use gene-editing tools to remove mutations in embryos which develop into human diseases. The team that comprised of the Oregon Health and Science University and other researchers were able to make breakthrough discoveries. The particular disease, hypertrophic cardiomyopathy, is passed down genetically and is a cause of many deaths especially among young athletes. It is not clear yet as to when the technology will be applied in the real world.

Read full article... Read full article...

 


Companies

Thursday, May 03, 2018

4 Biotech Stock Movers to Watch / Companies / BioTech

By: Harry_Boxer

Biotechs continue to dominate our list of top charts to watch.

CASI Pharmaceuticals Inc. (CASI) rose 48 cents, or 7.2%, to $7.14 on 773,700 shares Tuesday. The move came on no news, although the stock soared in early April on news that China's Food and Drug Administration (CFDA) would convene a panel to discuss its cancer therapy, Evomela. The stock has been flagging since that move, but may be positioning to break out, with the next target at $10.

Read full article... Read full article...

 


Companies

Monday, September 11, 2017

Could This Be The Biggest Biotech Breakthrough Of The Year? / Companies / BioTech

By: OilPrice_Com

Someone dies of a stroke every 4 minutes in the United States. Globally, 15 million people suffer a stroke every year. It’s debilitating physically and financially—but one little-known company has developed a medical device that hopes to challenge that deadly statistic.

It’s been quietly developing this new technology for 10 years. Now it’s released updated preliminary clinical trial results, and signed a manufacturing deal which could make a significant impact in the medical device industry.

After a decade of painstaking development, we’re now nearing the end of the long road to validation, and for investors who understand this industry, this could be the critical juncture.

Read full article... Read full article...

 


Companies

Wednesday, July 19, 2017

Biotech with Alzheimer's Focus Makes Progress on Several Fronts / Companies / BioTech

By: TLSReport

In its corporate update for Q2/17, a Canada-based biotech targeting neurological disorders including Alzheimer's disease informed investors of advancements in several programs, including designation of a second validated lead compound in development.

Among ProMIS Neurosciences Inc.'s (PMN:TSE) "key accomplishments" in the quarter, the company noted it expanded its potentially "best in class amyloid-beta (Aβ) portfolio for Alzheimer's disease," according to a July 10 news release. In its oral presentation, the company stressed its emphasis on the "best in class" goal, noting that even though Biogen Inc.'s (BIIB:NASDAQ) aducanumab will be "first in class" and is progressing well in development, the ProMIS compound could be more selective and possess greater patient benefits.

Read full article... Read full article...

 


Companies

Sunday, April 23, 2017

After The Crash - Digital And Regenerative Medicine, Live for Ever! / Companies / BioTech

By: John_Rubino

For most people, the doctor visit hasn’t changed in decades. Same physical waiting rooms, same paper forms to fill out, same slow, expensive tests and marginally-effective, maximally-invasive treatments. But that’s about to change, as a wave of new technologies drag medicine into the 21st century. Among the most interesting:

Read full article... Read full article...

 


Companies

Tuesday, April 18, 2017

The Smart Money Is Piling Into Regenerative Medicine / Companies / BioTech

By: John_Mauldin

BY PATRICK COX : The Congressional Budget Office released its long-term budget outlook. This report should have sparked a national discussion about societal aging, but big media largely ignored it.

Fortunately, there are signs that smart investors are hedging this failure by investing in regenerative medicine (RM).

Read full article... Read full article...

 


Companies

Wednesday, April 05, 2017

British Billionaire Jim Mellon Says Biotech Is the Best Investment Now / Companies / BioTech

By: John_Mauldin

BY PATRICK COX : We are in the midst of an unprecedented change. Life spans have nearly doubled since the beginning of the 20th century. In addition, recent advances in computer technology have had a huge impact on biological sciences, which means this trend will accelerate.

Still, most people think that the process of aging will go on pretty much as it is now. They’re wrong.

Read full article... Read full article...

 


Companies

Monday, March 13, 2017

... / Companies / BioTech

By: OilPrice_Com

...

 


Companies

Tuesday, February 28, 2017

Major Funds Betting On Trump BioTech Sector / Companies / BioTech

By: TLSReport

Donald Trump's presidency is a real nitro boost for the future of the biotech sector in the U.S., says Tom Beck, editor of Portfolio Wealth Global.

Donald Trump's presidency is a massive boost to all industries, and is a real nitro boost for the future of the biotech sector in the U.S.

With 80 million baby-boomers looking to stay young and vital for a very long time, you should be making your move, and market-beating returns will be occurring from the large-cap stocks and in the small-cap sector even more so.

Read full article... Read full article...

 


Companies

Tuesday, January 24, 2017

The Last Time This Happened, Biotech Stocks Plunged by 50% / Companies / BioTech

By: John_Mauldin

BY PATRICK WATSON : “They’re getting away with murder,” said Donald Trump at last week’s epic news conference.

No, he didn’t mean Russian hackers. He was talking about red-blooded American drug companies.

Trump went on: “Pharma has a lot of lobbyists and a lot of power, and there is very little bidding. We’re the largest buyer of drugs in the world, and yet we don’t bid properly, and we’re going to save billions of dollars.”

Read full article... Read full article...

 


Companies

Wednesday, January 18, 2017

Biotech Breakthrough Could Create A $11.4 Trillion Opportunity / Companies / BioTech

By: OilPrice_Com

....

 


Companies

Saturday, December 03, 2016

Can Biotech's Trump Bump Last? / Companies / BioTech

By: TLSReport

In the weeks since Donald Trump's presidential election victory, the stock markets have ridden a wave into positive—and in the case of the Dow, record-breaking—territory. The so-called Trump Bump also sent biotech indices, flaccid for much of the year, up as much as 15%. With the election now nearly a month old, and hot-button issues such as drug pricing still in the press, industry watchers have begun to weigh in on what might happen in the biotech and pharma markets when Trump takes office.

Read full article... Read full article...

 


Economics

Monday, November 21, 2016

Trump Can Fix US Economy by Embracing Biotech / Economics / BioTech

By: John_Mauldin

BY PATRICK COX : The presidential campaign made one fact very clear. Most of the media and public aren't focused on economic growth.

Growth powers and funds everything else. Just take a look at the enormous federal deficit and you’ll see that economic health keeps taking a back seat to short-term goals.

Yes, John Maynard Keynes made a case for using debt to stimulate the economy. But he never said anything about permanent deficits. And that is our current practice. The result is that taxpayers’ options will be curtailed in the future.

Read full article... Read full article...

 


Companies

Thursday, November 03, 2016

The Rise in Infectious Diseases Means Opportunity for Biotech Investors / Companies / BioTech

By: John_Mauldin

BY PATRICK COX : The CDC has expanded its count of Miami neighborhoods with verified local transmission of the Zika virus. As a result, pregnant women are taking precautions. Some have left the area. Others are donning hazmat suits.

At least one case of locally acquired Zika has been confirmed on Florida’s Gulf Coast where I live, and there are probably more. This is because most people don’t know that they’ve been infected and are carriers.

Read full article... Read full article...

 


Companies

Wednesday, September 21, 2016

Imagin, a Better Way to Detect Bladder Cancer / Companies / BioTech

By: TLSReport

Bob Moriarty profiles Imagin Medical, a company that has developed a new way of detecting bladder cancer through endoscopes.

The most common cancers in the U.S. are hardly the most expensive to treat. More Americans come down with breast cancer and lung cancer than any other types of cancer. The worst cancer from a perspective of expense turns out to be bladder cancer that is only the 6th most prevalent form of disease.

Read full article... Read full article...

 


Stock-Markets

Thursday, September 15, 2016

Great Day for Biotech Stocks / Stock-Markets / BioTech

By: Harry_Boxer

The stock market indices rebounded smartly in the morning, but got up to overhead resistance, particularly on the Nasdaq 100, which failed several times trying to get through 4770. At that point, the S&P 500 was trailing badly. They then went into an afternoon decline, and orderly retraced channel, 5-wave decline on the S&P 500, and then dropped right back to the 2120 level it reached twice in three days. This was the third test. That was successful. It bounced a few points off that level. It was not exactly a rip-roaring rally, but, nevertheless, support held for now, with the S&P 500 having a triple bottom, and the Nasdaq 100 having a right-handed, extended V-pattern, or rising wedge. No question with overhead resistance at 4770, or thereabouts on the Nasdaq 100, as well as for starters 2140-5 zone on the S&P 500 is going to be critical going forward.

Read full article... Read full article...

 


Companies

Wednesday, June 08, 2016

Investment in Cell and Gene Therapies Ramps Up / Companies / BioTech

By: TLSReport

After decades of disappointment, cell therapies and gene therapies are finally seeing light at the end of the tunnel. Investors, investigators, clinicians, and patients with serious unmet needs are watching pivotal trials move into the home stretch. Yes. . .pivotal data are actually on the way.

Though the roadblocks that have held back development of cell and gene therapies since the mid-1990s have been expensive in terms of a lingering hangover with depressed valuations, investors are now looking at achievement in terms of meaningful endpoints.

Read full article... Read full article...

 


Companies

Tuesday, June 07, 2016

Detecting Cancer With White and Blue Light / Companies / BioTech

By: Richard_Mills

Endoscopy is often used in the prevention, early detection, diagnosis, staging, and treatment of cancer.

X-rays and CT scans can show physical changes within the body and give information about the size, shape, and location of the changes. Endoscopes show details like color and surface texture allowing doctors to see exactly what’s going on.

If you go to a doctor exhibiting certain symptoms, endoscopy could be used to find the cause:

Read full article... Read full article...

 


Companies

Thursday, April 07, 2016

IBB (Biotech ETF) Baby Bull Market / Companies / BioTech

By: Gary_Savage

Here we go again. Remember when I warned traders not to short the baby bull in miners and exhorted them to not lose their position because surprises would come to the upside? Needless to say, many ignored that advice and they cost themselves dearly.

Now we have a second baby bull just getting started in Biotech. It still has a long ways to go. Yet I’m seeing some traders making the same mistakes again.

Read full article... Read full article...

 


Companies

Thursday, March 10, 2016

Seven Small-Cap Biotech Stocks on the Upswing 2016 / Companies / BioTech

By: TLSReport

Biotech stocks—and the stock market in general—took a dive at the beginning of 2016, headed down on macroeconomic factors such as financial instability in China. The Life Sciences Report's 2016 Small-Cap Biotech Watchlist was not immune to that movement, heading into negative territory almost from the moment the selected companies were introduced. But as the market has shown signs of rebounding, so too has the Watchlist.

Read full article... Read full article...

 


Page << | 1 | 2 | 3 | 4 | >>